Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up

Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up

http://theroc.us/researchlibrary/Cannabinoids%20in%20multiple%20sclerosis%20(CAMS)%20study-%20safety%20and%20efficacy%20data%20for%2012%20months%20follow%20up.pdf